Trial Profile
Clinical Trials Insight: 700021028
Status:
Not stated
Phase of Trial:
Phase I
Latest Information Update: 19 Feb 2007
Price :
$35
*
At a glance
- Drugs HRG 214 (Primary)
- Indications HIV infections
- Focus Adverse reactions
- 19 Feb 2007 New trial record.